首页 | 本学科首页   官方微博 | 高级检索  
     

COX-2在甲状腺相关眼病眼眶脂肪增生中的作用
引用本文:王浩,魏锐利. COX-2在甲状腺相关眼病眼眶脂肪增生中的作用[J]. 国际眼科纵览, 2012, 36(5): 336-340
作者姓名:王浩  魏锐利
作者单位:第二军医大学上海长征医院眼科, 上海,200433
基金项目:国家自然科学基金面上项目,国家自然科学基金青年项目
摘    要:甲状腺相关眼病(thyroid-associatedophthalmopathy,TAO)是一种自身免疫性疾病,发病机制与成纤维细胞和T细胞的相互作用所致炎症反应有关,脂肪增生是其重要的病理过程。环氧化酶-2(cyclooxygenase-2,COX-2)是一种重要的致炎因子,与多种自身免疫疾病的炎症过程相关。TAO患者眼眶中活化的T淋巴细胞过量表达COX-2,并通过与眼眶CD90-成纤维细胞表达的过氧化物酶体增生物激活受体1(peroxisomeproliferatoractivatedreceptor1,PPARγ)结合,诱导CD90-眼眶成纤维细胞分化为成熟脂肪细胞,从而促进眼眶脂肪增生的发生,因此COX-2在TAO眼眶脂肪增生中起重要作用。(国际眼科纵览,2012,36:336-340)

关 键 词:甲状腺相关眼病  环氧化酶-2  脂肪增生

Research progression on cyclooxygen-2 in adipogenesis of thyroid associated ophthalmopathy
WANG Hao , WEI Rui-li. Research progression on cyclooxygen-2 in adipogenesis of thyroid associated ophthalmopathy[J]. International Review of Opthalmology, 2012, 36(5): 336-340
Authors:WANG Hao    WEI Rui-li
Affiliation:. Department of Ophthalmology, Shanghai Changzheng hospital, Affiliated to Second Mili- tary Medical University, Shanghai 200433, China
Abstract:Thyroid associated ophthalmopathy (TAO) is an autoimmune disease, it' s pathogenesis related to the inflammation caused by reaction between T cell and orbital fibroblasts, and adipogenesis is an important pathological procedure. Cyclooxygenase-2 ( COX -2) is an important proinflammatory factor associ- ated with inflammatory process of various autoimmune diseases. Recent studies have shown that COX-2 plays an important role in TAO orbital fat proliferation. Activated T lymphocytes in the orbit of TAO patients over- express COX-2, which could induct the differentiation of CD90 - orbital fibroblasts into mature adipocytes through combination with peroxisome proliferator activated receptor γ (PPARγ) expressed on the surface of CD90- orbital fibroblasts, thereby promoting the occurrence of orbital fat proliferation. (Int Rev Ophthal- mol, 2012, 36: 336-340)
Keywords:thyroid associated ophthalmopathy  cyclooxygen-2  adipogenesis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号